| Followers | 54 |
| Posts | 6684 |
| Boards Moderated | 0 |
| Alias Born | 01/11/2017 |
Monday, March 06, 2023 3:01:30 PM
Lies is a strong accusation!
I’m not a fan of AF but let’s stick to the facts!
On May 10, were the endpoints for the ORIGINAL trial updated to reflect that O/S was the primary and secondary endpoints??
I’ll help you with the answer: it’s NO!
So whether this slippery “bio expert” wrote his hit piece, he relied on the very resources that are standard. And what he found were endpoints that technically failed! Follow me: because the pseudo progression was found, the trial took that into account HOWEVER the website wasn’t updated so AF is in the clear! As a matter of fact, it’s been rumored on this board that LP knew that to be true and attempted to seek a stock halt..:on the OTC! Rookie error!
Then whether LL was truly sick is open to anyone’s interpretation if they have an agenda, such as AF. Another rookie error! Could LL not done that by Zoom so people could be safe and hear it from the lead trial oncologist? Another rookie error!
Time and again, Linda gets outsmarted by fools like AF.
Once y’all take out bias and hope, you’re stuck with facts. Facts that judges review without bias or prejudice.
We can argue this all you want however I simply look at the ticket every day. I see “red” with low volume. Spoofing isn’t causing that! It’s been three months since the last PR, which they congratulated themselves for getting enough “yes” votes to add 500mm more shares and give themselves nice bonuses.
Sorry this doesn’t agree with your hope and wants, but it’s reality. I hope it works out for everyone but until approval is granted and this is in doctors hands for use on cancer patients, it’s worth $.65
I’m not a fan of AF but let’s stick to the facts!
On May 10, were the endpoints for the ORIGINAL trial updated to reflect that O/S was the primary and secondary endpoints??
I’ll help you with the answer: it’s NO!
So whether this slippery “bio expert” wrote his hit piece, he relied on the very resources that are standard. And what he found were endpoints that technically failed! Follow me: because the pseudo progression was found, the trial took that into account HOWEVER the website wasn’t updated so AF is in the clear! As a matter of fact, it’s been rumored on this board that LP knew that to be true and attempted to seek a stock halt..:on the OTC! Rookie error!
Then whether LL was truly sick is open to anyone’s interpretation if they have an agenda, such as AF. Another rookie error! Could LL not done that by Zoom so people could be safe and hear it from the lead trial oncologist? Another rookie error!
Time and again, Linda gets outsmarted by fools like AF.
Once y’all take out bias and hope, you’re stuck with facts. Facts that judges review without bias or prejudice.
We can argue this all you want however I simply look at the ticket every day. I see “red” with low volume. Spoofing isn’t causing that! It’s been three months since the last PR, which they congratulated themselves for getting enough “yes” votes to add 500mm more shares and give themselves nice bonuses.
Sorry this doesn’t agree with your hope and wants, but it’s reality. I hope it works out for everyone but until approval is granted and this is in doctors hands for use on cancer patients, it’s worth $.65
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
